» Articles » PMID: 8266370

Venous Sinus Thrombosis Associated with Androgens in a Healthy Young Man

Overview
Journal Stroke
Date 1994 Jan 1
PMID 8266370
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebral venous sinus thrombosis is rare and can be promoted by various conditions. We report the case of cerebral venous thrombosis in a patient using androgens.

Case Description: A 31-year-old man using androgens for bodybuilding was admitted for headache and vomiting. He had cerebral venous sinus thrombosis, but extensive examinations did not reveal any known cause.

Conclusions: We suggest that androgens may promote cerebral venous thrombosis. The mechanisms of venous thrombosis related to androgens may be platelet activation or an increase in coagulation factors. Because androgen use may be frequent and hidden in athletes, it may be an underestimated cause of cerebral venous sinus thrombosis in the young.

Citing Articles

Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review.

Rosca A, Vladareanu A, Mititelu A, Popescu B, Badiu C, Caruntu C J Clin Med. 2021; 10(1).

PMID: 33406783 PMC: 7795962. DOI: 10.3390/jcm10010147.


Deep Cerebral Venous Thrombosis Treatment : Endovascular Case using Aspiration and Review of the Various Treatment Modalities.

Yeo L, Lye P, Yee K, Cunli Y, Ming T, Ho A Clin Neuroradiol. 2020; 30(4):661-670.

PMID: 32529307 DOI: 10.1007/s00062-020-00920-3.


A Case Study of Deep Vein Thrombosis of the Right Internal Jugular Vein in a Healthy 21-Year-Old Male.

Corral J, Villanueva G Case Rep Hematol. 2016; 2016:7654749.

PMID: 27725891 PMC: 5048042. DOI: 10.1155/2016/7654749.


Cortical venous thrombosis following exogenous androgen use for bodybuilding.

Sveinsson O, Herrman L BMJ Case Rep. 2013; 2013.

PMID: 23389726 PMC: 3604349. DOI: 10.1136/bcr-2013-008638.


Anabolic steroids and cardiovascular risk.

Angell P, Chester N, Green D, Somauroo J, Whyte G, George K Sports Med. 2012; 42(2):119-34.

PMID: 22229259 DOI: 10.2165/11598060-000000000-00000.